semaglutide ophthalmology Anterior ischemic optic neuropathy in patients treated with semaglutide: report of four cases with a possible association | BMC A new study suggests patients

Leyson-Azuela, RMT, MD, MPH, is a physician, medical writer, and researcher with a strong background in public health, clinical medicine, and academic instruction

Whether you are weeks into your first dose or months into a stable protocol, understanding your lab work transforms you from a passive patient into someone who can actually read the data and make informed decisions about your health

What to Expect at Each Dose Level Based on the Phase 2 NEJM study (Jastreboff et al., 2023) and the TRIUMPH-4 Phase 3 results

Bottom line GLP-1 medications, or glucagon-like peptide-1 receptor agonists, treat type 2 diabetes and, in some cases, obesity

Fourth, the use of pseudo-observations at zero dose, while methodologically justified to stabilize model behavior at the lower boundary, represents a modeling assumption that may influence extrapolation outside the observed dose range